Anti-Monopoly Regulation On Excessive Pricing Behaviors In Pharmaceutical Sector

The importance of medicines is not to be overstated.No one can leave without drugs.However,if the problem arises in the price of medicines,it will inevitably have an impact on the health of the whole people.From a more far-reaching point of view,it will also affect social harmony and stability.In recent years,the pharmaceutical industry has also flourished and is moving towards more modern and scientific progress.At this stage,the domestic market economy is in a stage of rapid development.At the same time,it has also driven the development of the pharmaceutical industry,which has made the competition pressure in the industry increasingly increasing.What followed is the emergence of ultra-high pricing of drugs.Excessive pricing behavior relies on the unique advantages of the drug,which is a kind of exploitation of consumers.At this level,it can be regard as exploitative abuse.How to maintain a normal economic order,ensure that consumers' rights and interests are not infringed,effectively regulate drug prices,and avoid market monopoly,etc.These are the most critical development goals of the domestic pharmaceutical market.The reasons for the excessive pricing in pharmaceutical sector are very complicated,which are mainly reflected in:First,the high commercial bribery expenses incurred by pharmaceutical companies for illegitimate interests,and this expense will have to be paid by consumers eventually;Second,the superiority of pharmaceutical patents give the pharmaceutical company exclusive status in the patent period,so the pharmaceutical company can obtain excessive profits during the period;Third,in the patent cliff period,the original drug enterprise is unwilling to accept huge profit gap for the patent that is about to expire,so pharmaceutical companies will continue to keep exclusive status in two ways.Excessive pricing of drugs have attracted much attention from all sectors of society.The incessant anti-monopoly enforcement cases demonstrate the determinations of the anti-monopoly law enforcement authorities to regulate the excessive medicine prices,however,due to the complicated situations,the effect of the governance is far from satisfactory.The pharmaceutical industry is characterized by complexity and specificity compared to other industries.Drugs in the market circulation will go through multiple trading links,which is relatively complicated,leading to a monopoly in the pharmaceutical market.These have a great impact on the sustainable development of the pharmaceutical market,so it is very urgent to quickly regulate the market and avoid price monopoly.The reason why the domestic pharmaceutical industry has such problems is directly related to the lack of the current legal system.The supporting laws need to be improved.There are legal gaps in many places,and law enforcement is in the form.These problems are urgently needed to be resolved.The pharmaceutical import and export market in Western countries has always been relatively large in scale,and its R&D technology is relatively advanced.It is at the global advanced level and has achieved many successful management experiences on the monopoly of drug prices.Strengthening the cooperation between anti-monopoly administrative government and industry regulation organization.According to our country's basic national conditions,in the multifaceted construction at the legislative level,law enforcement level,and industry level,we can find out the regulatory counter measures for anti-monopoly of drug pricing,and combined with their own needs,and constantly improve drug price monopoly law regulation.